FindTrial
Sign In

the effectivity and safety of medications for patients with restless legs syndrome: a real-world study

diagnosis and treatment of patients with restless legs syndrome: a real world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040784
Enrollment
Unknown
Registered
2020-12-10
Start date
2019-03-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restless legs syndrome

Interventions

Case series:none

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with restless legs syndrome which was diagnosed according to the 2014 International Restless Legs Syndrome Study Group (RLSSG) diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Patients who didn't sign the informed consent; 2. Patients who unable to evaluate the primary endpoint.

Design outcomes

Primary

MeasureTime frame
the severity of restless legs syndrome;—

Countries

China

Contacts

Public ContactLisan Zhang

Xiasha Campus, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

zls09@zju.edu.cn+86 13805752614

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026